Cyclin K and cyclin D1b are oncogenic in myeloma cells

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Marsaud, Véronique ^a   Tchakarska, Guergana ^b   Andrieux, Geoffroy ^b   Liu, Jian Miao ^c   Dembele, Doulaye ^d   Jost, Bernard ^d   Wdzieczak Bakala, Joanna ^c   Renoir, Jack Michel ^a   Sola, Brigitte ^b  

^a UNIV PARIS SUD   (France)

^b UNIVERSITÉ DE CAEN   (France)

^c INSTITUT DE CHIMIE DES SUBSTANCES NATURELLES   (France)

^d INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1B; CYCLIN K; CYCLINE; UNCLASSIFIED DRUG; CCND1 PROTEIN, HUMAN; CCNK PROTEIN, HUMAN; CYCLIN D1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL CYCLE REGULATION; CELL METABOLISM; CELL MIGRATION; CLONOGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENOME ANALYSIS; MOUSE; MYELOMA CELL; NONHUMAN; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; TRANSLATION REGULATION; TUMOR VASCULARIZATION; ANIMAL; CELL CYCLE; CELL LINE; CELL MOTION; CELL SEPARATION; CHICK EMBRYO; DNA MICROARRAY; FLOW CYTOMETRY; GENETICS; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; METABOLISM; MULTIPLE MYELOMA; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MUS;

ANIMALS; CELL CYCLE; CELL LINE; CELL MOVEMENT; CELL SEPARATION; CHICK EMBRYO; CYCLIN D1; CYCLINS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; MULTIPLE MYELOMA; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77951940993     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-103     Document Type: Article

References (46)

1. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD, Heighway J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene 1995, 11:1005-1011.
2. Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998, 12:3499-3511. 10.1101/gad.12.22.3499, 317244, 9832503.
3. Alt JR, Cleveland JL, Hannink M, Diehl JA. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev 2000, 15:3102-3114.
4. Lu F, Gladden AB, Diehl JA. An alternative spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Res 2003, 63:7056-7061.
5. Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, Senderowicz AM, Conti CJ, Knudsen ES. Cyclin D1 splice variants. J Biol Chem 2003, 278:30339-30447. 10.1074/jbc.M303969200, 12746453.
6. Holley SL, Heighway J, Hoban PR. Induced expression of human CCND1 alternative transcripts in mouse Cyl-1 knockout fibroblasts highlights functional differences. Int J Cancer 2005, 114:364-370. 10.1002/ijc.20750, 15551329.
7. Lin DI, Lessie MD, Gladden AB, Bassing CH, Wagner KU, Diehl JA. Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis. Oncogene 2008, 27:1231-1242. 10.1038/sj.onc.1210738, 17724472.
8. Gladden AB, Woolery R, Aggarwal P, Wasik MA, Diehl JA. Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma. Oncogene 2006, 25:998-1007. 10.1038/sj.onc.1209147, 2832762, 16247460.
9. Javiluoma A, Ojala PM. Cell signaling pathways engaged by KSHV. Biochim Biophys Acta 2006, 1766:140-158.
10. Verschuren EW, Hodgson JG, Gray JW, Kogan S, Jones N, Evan GI. The role of p53 in suppression of KSHV cyclin-induced lymphomagenesis. Cancer Res 2004, 64:581-589. 10.1158/0008-5472.CAN-03-1863, 14744772.
11. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 1994, 13:2124-2130. 395065, 8187765.
12. Lovec H, Grzeschiczek A, Kowalski MB, Möröy T. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J 1994, 13:3487-3495. 395252, 8062825.
13. Bergsagel PL, Kuehl WM. Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol 2005, 23:6333-6338. 10.1200/JCO.2005.05.021, 16155016.
14. Jares P, Colomer D, Campo E. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 2007, 7:750-762. 10.1038/nrc2230, 17891190.
15. Marzec M, Kasprzycka M, Lai R, Gladden AB, Wlodarski P, Tomczak E, Nowell P, Deprimo SE, Sadis S, Eck S, Schuster SJ, Diehl JA, Wasick MA. Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase. Blood 2006, 108:1744-1750. 10.1182/blood-2006-04-016634, 1895502, 16690963.
16. Krieger S, Gauduchon J, Roussel M, Troussard X, Sola B. Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma. BMC Cancer 2006, 6:238. 10.1186/1471-2407-6-238, 1609182, 17022831.
17. Lundquist A, Barré B, Bienvenu F, Hermann J, Avril S, Coqueret O. Kaposi sarcoma-associated viral cyclin K overrides cell growth inhibition mediated by oncostatin M through STAT3 inhibition. Blood 2003, 101:4070-4077. 10.1182/blood-2002-07-1994, 12531804.
18. Lévêque C, Marsaud V, Renoir JM, Sola B. Alternative cyclin D1 forms a and b have different biological functions in the cell cycle of B lymphocytes. Exp Cell Res 2007, 313:2719-2729. 10.1016/j.yexcr.2007.04.018, 17499716.
19. Le Brigand K, Russel R, Moreilhon C, Rouillard J-M, Jost B, Amiot F, Magnone V, Bole-Feysot C, Rostagno P, Virolle V, Defamie V, Dessen P, Williams G, Lyons P, Rios G, Mari B, Gulari E, Kastner P, Gidrol X, Freeman TC, Barbry P. An open-access long oligonucleotide microarray resource for analysis of the human and mouse transcriptomes. Nucleic Acids Research 2006, 34:e87. 10.1093/nar/gkl485, 1524919, 16855282.
20. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995, 57:289-300.
21. Hagedorn M, Zilberberg L, Wilting J, Canron X, Carrabba G, Giussani C, Pluderi M, Bello L, Bikfalvi A. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors. Cancer Res 2002, 62:6884-6890.
22. Hurt EM, Wiestner A, Rosenwald A, Schaffer AL, Campo E, Grogan T, Bergsagel PL, Kuehl WM, Staudt LM. Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow. Cancer Cell 2004, 5:191-199. 10.1016/S1535-6108(04)00019-4, 14998494.
23. Li Z, Jiao X, Wang C, Ju X, Lu Y, Yuan L, Lisanti MP, Katiyar S, Pestell RG. Cyclin D1 induction of cellular migration requires p27KIP1. Cancer Res 2006, 66:9986-9994. 10.1158/0008-5472.CAN-06-1596, 17047061.
24. Takei Y, Kadomatsu K, Yuzawa Y, Matsuo S, Muramatsu T. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res 2004, 64:3365-3370. 10.1158/0008-5472.CAN-03-2682, 15150085.
25. Moreno-Bueno G, Rodríguez-Perales S, Sánchez-Estévez C, Hardisson D, Sarrió D, Prat J, Cigudosa JG, Matias-Guiu X, Palacios J. Cyclin D1 gene (CCND1) mutations in endometrial cancer. Oncogene 2003, 22:6115-6118. 10.1038/sj.onc.1206868, 12955092.
26. Benzeno S, Lu F, Guo M, Barbash O, Zhang F, Herman JG, Klein PS, Rustgi A, Diehl JA. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. Oncogene 2006, 25:6291-6303. 10.1038/sj.onc.1209644, 16732330.
27. Sakamaki T, Casimiro MC, Ju X, Quong AA, Katiyar S, Liu M, Jiao X, Li A, Zhang X, Lu Y, Wang C, Byers S, Nicholson R, Link T, Shemluck M, Yang J, Fricke ST, Novikoff PM, Papanikolaou A, Arnold A, Albanese C, Pestell R. Cyclin D1 determines mitochondrial function in vivo. Mol Cell Biol 2006, 26:5449-5469. 10.1128/MCB.02074-05, 1592725, 16809779.
28. Wang C, Li Z, Lu Y, Du R, Katiyar S, Yang J, Fu M, Leader JE, Quong A, Novikoff PM, Pestell RG. Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function. Proc Natl Acad Sci USA 2006, 31:11567-11572.
29. Gogvadze V, Orreniius S, Zhivotovsky B. Mitochondria in cancer cells: what is so special about them?. Trends Cell Biol 2008, 18:165-173. 10.1016/j.tcb.2008.01.006, 18296052.
30. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Cyclin D1: normal and abnormal functions. Endocrinology 2005, 145:5439-5447.
31. Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez RV, Kittrell FS, Zahnow CA, Patterson N, Golub TR, Ewen ME. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 2003, 114:323-334. 10.1016/S0092-8674(03)00570-1, 12914697.
32. Gandin V, Miluzio A, Barbieri AM, Beugnet A, Kiyokawa H, Marchisio PC, Biffo S. Eukaryotic initiation factor is rate-limiting in translation, growth and transformation. Nature 2008, 455:684-688. 10.1038/nature07267, 2753212, 18784653.
33. Li Z, Wang C, Jiao X, Katiyar S, Casimiro MC, Prendergast GC, Powell MJ, Pestell RG. Alternate cyclin D1 mRNA splicing modulates P27KIP1 binding and cell migration. J Biol Chem 2008, 283:7007-7015. 10.1074/jbc.M706992200, 18180298.
34. Baek K, Brown RS, Birrane G, Ladias JA. Crystal structure of human cyclin K, a positive regulator of cyclin-dependent kinase 9. J Mol Biol 2007, 366:563-573. 10.1016/j.jmb.2006.11.057, 1852425, 17169370.
35. Yasui M, Yamamoto H, Ngan CY, Damdinsuren B, Sugita Y, Fukunaga H, Gu J, Maeda M, Takemasa I, Ikeda M, Fujio Y, Sekimoto M, Matsuura N, Weinstein IB, Monden M. Antisense to cyclin D1 inhibits vascular endothelial growth factor - stimulated growth of vascular endothelial cells: implication for tumor development. Clin Cancer Res 2006, 12:4720-4729. 10.1158/1078-0432.CCR-05-1213, 16899623.
36. Hideshima T, Mitsiades C, Tonon G, Richardson PG, Anderson KC. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer 2007, 7:585-598. 10.1038/nrc2189, 17646864.
37. Hose D, Moreaux J, Meissner T, Seckinger A, Goldschmidt H, Benner A, Mahtouk K, Hillengass J, Rème T, De Vos J, Hundemer M, Condomines M, Bertsch U, Rossi J-F, Jauch A, Klein B, Möhler T. Induction of angiogenesis by normal and malignant plasma cells. Blood 2009, 114:128-143. 10.1182/blood-2008-10-184226, 19299335.
38. Claudio JO, Masih-Khan E, Tang H, Gonçalves J, Voralia M, Li ZH, Nadeem V, Cukerman E, Francisco-Pabalan O, Liew CC, Woodgett JR, Stewart AK. A molecular compendium of genes expressed in multiple myeloma. Blood 2002, 100:2175-2186. 10.1182/blood-2002-01-0008, 12200383.
39. De Vos J, Thykjaer T, Tarte K, Ensslen M, Raynaud P, Requirand G, Pellet F, Pantesco V, Rème T, Jourdan M, Rossi JF, Ørntoft T, Klein B. Comparison of gene expression between malignant and normal plasma cells with oligonucleotide array. Oncogene 2002, 21:6848-6857. 10.1038/sj.onc.1205868, 12360412.
40. Davies FE, Dring AM, Li C, Rawstron AC, Shammas MA, O'Connor SM, Fenton JA, Hideshima T, Chauhan D, Tai IT, Robinson E, Auclair D, Rees K, Gonzalez D, Ashcroft AJ, Dasgupta R, Mitsiades C, Mitsiades N, Chen LB, Wong WH, Munshi NC, Morgan GJ, Anderson KC. Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis. Blood 2003, 102:4505-4511.
41. Munshi NC, Hideshima T, Carrasco D, Shammas M, Auclair D, Davies F, Mitsiades N, Mitsiades C, Kim RS, Li C, Rajkumar SV, Fonseca R, Bergsagel L, Chauhan D, Anderson KC. Identification of genes modulated in multiple myeloma using genetically identical twin samples. Blood 2004, 103:1799-1806. 10.1182/blood-2003-02-0402, 12969976.
42. Heller G, Schmidt WM, Ziegler B, Holzer S, Müllauer L, Bilban M, Zielinski CC, Drach J, Zöchbauer-Müller S. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin in multiple myeloma cells. Cancer Res 2008, 68:44-54. 10.1158/0008-5472.CAN-07-2531, 18172295.
43. Batsche E, Yaniv M, Muchardt C. The human SWI/SNF subunit Brm is a regulator of alternative splicing. Nat Struct Mol Biol 2006, 13:22-29. 10.1038/nsmb1030, 16341228.
44. Sanchez G, Bittencourt D, Laud K, Barbier J, Delattre O, Auboeuf D, Dutertre M. Alteration of cyclin D1 transcript elongation by a mutated transcripion factor up-regulates the oncogenic D1b splice isoform in cancer. Proc Natl Acad Sci USA 2008, 105:6004-6009. 10.1073/pnas.0710748105, 2329709, 18413612.
45. Wang Y, Dean JL, Millar EKA, Tran TH, McNeil CM, Burd CJ, Henshall SM, Utama FE, Witkiewicz A, Rui H, Sutherland RL, Knudsen KE, Knudsen ES. Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists. Cancer Res 2008, 68:5628-5638. 10.1158/0008-5472.CAN-07-3170, 18632615.
46. Millar EK, Dean JL, McNeil CM, O'Toole SA, Henshall SM, Tran T, Lin J, Quong A, Comstock CE, Witkiewicz A, Musgrove EA, Rui H, Lemarchand L, Setiawan VW, Haiman CA, Knudsen KE, Sutherland RL, Knudsen ES. Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists. Oncogene 2009, 28:1812-1820. 10.1038/onc.2009.13, 19287456.